Indefinite Delivery Contract SPE2DX15D9990

DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a single-award Indefinite Delivery Contract (SPE2DX) by the Medical Supply Chain division of the Department of Defense on August 26, 2025, with a ceiling value of $4,999,999 and an ultimate completion date of November 13, 2026. This contract establishes a framework for the delivery of a comprehensive range of pharmaceutical products to support military healthcare facilities and federal medical supply requirements nationwide. The contract utilizes firm fixed-price delivery orders, enabling the government to procure specific pharmaceutical items as needed throughout the contract period without requiring competitive rebidding for individual purchases.

The initial delivery orders issued under this Indefinite Delivery Contract, all awarded on August 22, 2025, with completion dates of August 25, 2025, reflect the contract's scope across multiple pharmaceutical categories. These orders include Penicillin VK 250 mg tablets, Mupirocin 2% ointment, and Diazepam 10 mg/2 ml Carpuject injections, with individual order values ranging from $23 to $375, totaling $783 across the six delivery orders documented. All orders are performed at the contractor's facility in Park Ridge, Illinois 60068. This contract leverages DMS Pharmaceutical Group's established position as a critical supplier within the federal pharmaceutical supply chain, enabling efficient procurement of both common antibiotics and specialty medications required by military medical facilities.